FDA Approved: VILTEPSO — Original Application (NS Pharma, Inc.)

View source ↗

Summary

The FDA approved Viltepso (viltolarsen) from NS Pharma, Inc. under Original NDA212154 for Duchenne muscular dystrophy amenable to exon 53 skipping.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Viltepso (viltolarsen)

Snippet

ORIG AP for VILTEPSO (VILTOLARSEN)